A Real-World Observational Study Evaluating Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes
posted on 2020-05-18, 09:13authored byMike Baxter, Yukiko Morimoto, Masami Tamiwa, Masakatsu Hattori, Xuejun Victor Peng, Robert Lubwama, Hiroshi Maegawa
The above Summary Slide and Plain Language Summary represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).